Yonsei Med J.  2008 Apr;49(2):189-199. 10.3349/ymj.2008.49.2.189.

The Evolution of KTP Laser Vaporization of the Prostate

• Sountoulides P
• Tsakiris P

• KMID: 1084489
• DOI: http://doi.org/10.3349/ymj.2008.49.2.189

Abstract

The search for a minimally invasive approach to the treatment of Lower Urinary Tract Symptoms (LUTS) suggestive of Benign Prostatic Hyperplasia (BPH) is probably as old as Transurethral Resection of the Prostate (TURP). In an effort to overcome the limitations and morbidities of TURP, and in light of evidence suggesting that medical treatment for BPH has a limited life-span, laser-based treatments have emerged during the last decade. Photoselective Vaporization of the Prostate (PVP) by the "GreenLight" KTP laser is considered one of the most promising options, one that is constantly evolving new technologies in prostate surgery. In this overview of KTP laser usage in BPH treatment, we will briefly discuss the evolution of this modality since it was first introduced and focus on the available evidence regarding safety, efficacy and cost parameters of its application.

Keyword

Lasers; benign prostatic hyperplasia; surgery

MeSH Terms

Humans
Laser Therapy/*methods/trends
Male
Prostate/pathology/*surgery
Prostatic Hyperplasia/*surgery

Reference

1. Rassweiler J, Schulze M, Stock C, Teber D, De La Rosette J. Bipolar transurethral resection of the prostate-technical modifications and early clinical experience. Minim Invasive Ther Allied Technol. 2007. 16:11–21.

2. Yoon CJ, Kim JY, Moon KH, Jung HC, Park TC. Transurethral resection of the prostate with a bipolar tissue management system compared to conventional monopolar resectoscope: one-year outcome. Yonsei Med J. 2006. 47:715–720.

3. Park DS, Cho TW, Lee YK, Lee YT, Hong YK, Jang WK. Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia. Yonsei Med J. 2006. 47:706–714.

4. Barber NJ, Muir GH. High-power KTP laser prostatectomy: the new challenge to transurethral resection of the prostate. Curr Opin Urol. 2004. 14:21–25.

5. Lee R, Gonzalez RR, Te AE. The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia. World J Urol. 2006. 24:405–409.

6. Te AE. The next generation in laser treatments and the role of the GreenLight high-performance system laser. Rev Urol. 2006. 8:Suppl 3. S24–S30.

7. Rajbabu K, Dudderidge T, Barber N, Walsh K, Muir G. Evaluation of ideal irrigation fluid in 'Greenlight' photoselective vapourization of the prostate. Prostate Cancer Prostatic Dis. 2007. 10:101–103.

8. Barber NJ, Zhu G, Donohue JF, Thompson PM, Walsh K, Muir GH. Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate. Urology. 2006. 67:80–83.

9. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology. 1997. 49:703–708.

10. Costello AJ, Johnson DE, Bolton DM. Nd:YAG laser ablation of the prostate as a treatment for benign prostatic hypertrophy. Lasers Surg Med. 1992. 12:121–124.

11. Hoffman RM, MacDonald R, Slaton JW, Wilt TJ. Laser prostatectomy versus transurethral resection for treating benign prostatic obstruction: a systematic review. J Urol. 2003. 169:210–215.

12. Watson G. Contact laser prostatectomy. World J Urol. 1995. 13:115–118.

13. Miki T, Kojima Y, Nonomura N, Matsumiya K, Kokado Y, Yoshioka T, et al. Transurethral visual laser ablation of the prostate for benign prostatic hyperplasia using a KTP/YAG laser. Int J Urol. 1997. 4:576–579.

14. Shingleton WB, Terrell F, Renfroe L, Kolski J, Fowler JE Jr. Low-power v high-power KTP laser: improved method of laser ablation of prostate. J Endourol. 1999. 13:49–52.

15. Kollmorgen TA, Malek RS, Barrett D. Laser prostatectomy: two and a half years' experience with aggressive multifocal therapy. Urology. 1996. 48:217–222.

16. Langley SE, Gallegos CR, Moisey CU. A prospective randomized trial evaluating endoscopic Nd:YAG laser prostate ablation with or without potassium titanyl phosphate (KTP) laser bladder neck incision. Br J Urol. 1997. 80:880–884.

17. Carter A, Sells H, Speakman M, Ewings P, MacDonegh R, O'Boyle P. A prospective randomized controlled trial of hybrid laser treatment or transurethral resection of the prostate, with a 1-year follow-up. BJU Int. 1999. 83:254–259.

18. Pearcy RM, Carter A, Sells H, O'Boyle P. Hybrid KTP/Nd:YAG laser treatment of the prostate versus TURP: 18 months' follow-up data. BJU Int. 1999. 83:Suppl 4. 37.

19. Shingleton WB, Farabaugh P, May W. Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology. 2002. 60:305–308.

20. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology. 1996. 48:575–583.

21. Malek RS, Barrett DM, Kuntzman RS. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology. 1998. 51:254–256.

22. Malek RS, Kuntzman RS, Barrett DM. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol. 2000. 163:1730–1733.

23. Carter A, Sells H, O'Boyle PJ. High-power KTP laser for the treatment of symptomatic benign prostatic enlargement. BJU Int. 1999. 83:857–858.

24. Rajbabu K, Muir GH. GreenLight photoselective vaporization of prostate - a technical review. Prostate Cancer Prostatic Dis. 2007. 10:Suppl 1. S6–S9.

25. Haley R, Boddy J, Wharton I, Sami T, Ryan P, Devarajan R. A retrospective audit of TURP to assess the potential impact of Green Light Laser surgery on the diagnosis of prostate cancer [abstract]. Eur Urol Suppl. 2007. 6:195.

26. Bachmann A, Ruszat R, Wyler S, Reich O, Seifert HH, Müller A. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol. 2005. 47:798–804.

27. Sarica K, Alkan E, Lüleci H, Taşci AI. Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. J Endourol. 2005. 19:1199–1202.

28. Kaplan SA. Expanding the role of photoselective vaporization of the prostate. Rev Urol. 2006. 8:Suppl 3. S3–S8.

29. Hai MA, Malek RS. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol. 2003. 17:93–96.

30. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol. 2004. 172:1404–1408.

31. Sulser T, Reich O, Wyler S, Ruszat R, Casella R, Hofstetter A, et al. Photoselective KTP laser vaporization of the prostate: first experiences with 65 procedures. J Endourol. 2004. 18:976–981.

32. Dincel C, Samli M, Guler C, Demirbas M, Karalar M. Plasma kinetic vaporization of the prostate: clinical evaluation of a new technique. J Endourol. 2004. 18:293–298.

33. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int. 2006. 97:1229–1233.

34. Volkan T, Ihsan TA, Yilmaz O, Emin O, Selcuk S, Koray K, et al. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate. Eur Urol. 2005. 48:608–613.

35. Malek R, Kuntzman R, Barrett DM. Photoselective potassium-titanyl-phosphate laser vaporization of the benign obstructive prostate: observations on long-term outcomes. J Urol. 2005. 174:1344–1348.

36. Bachmann A, Ruszat R. The KTP-(greenlight-) laser-principles and experiences. Minim Invasive Ther Allied Technol. 2007. 16:5–10.

37. Reich O, Gratzke C, Stief CG. Techniques and long-term results of surgical procedures for BPH. Eur Urol. 2006. 49:970–978. discussion 978.

38. Ruszat R, Wyler S, Forster T, Sulser T, Bachmann A. Complications of photoselective vaporization of the prostate [abstract]. Eur Urol Suppl. 2007. 6:136.

39. Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T. High power (80W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients. J Urol. 2005. 173:158–160.

40. Fu WJ, Hong BF, Wang XX, Yang Y, Cai W, Gao JP. Evaluation of greenlight photoselective vaporization of the prostate for the treatment of high-risk patients with benign prostatic hyperplasia. Asian J Androl. 2006. 8:367–371.

41. Parr NJ, Loh CS, Desmond AD. Transurethral resection of the prostate and bladder tumour without withdrawal of warfarin therapy. Br J Urol. 1989. 64:623–625.

42. Dotan ZA, Mor Y, Leibovitch I, Varon D, Golomb J, Duvdevani M, et al. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol. 2002. 168:610–613. discussion 614.

43. Ruszat R, Wyler S, Forster T, Reich O, Stief CG, Gasser TC, et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol. 2007. 51:1031–1038. discussion 1038-41.

44. Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology. 2004. 64:1155–1159.

45. Sandhu JS, Te AE. Photoselective vaporization of the prostate: the vaporization incision technique for large volume prostates [abstract]. J Urol. 2005. 173:4 Suppl. 366.

46. Ruszat R, Wyler S, Seifert HH, Reich O, Forster T, Sulser T, et al. Photoselective vaporization of the prostate: subgroup analysis of men with refractory urinary retention. Eur Urol. 2006. 50:1040–1049.

47. Hirst G, Edwards M, James W, Bose P. Comparison of TURP and photoselective vaporization of the prostate (PVP) in men presenting with painful acute urinary retention [abstract]. Eur Urol Suppl. 2007. 6:192.

48. Bachmann A, Schürch L, Ruszat R, Wyler SF, Seifert HH, Müller A, et al. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome. Eur Urol. 2005. 48:965–971. discussion 972.

49. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello A. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol. 2006. 20:580–585.

50. Bouchier-Hayes DM. Photoselective vaporization of the prostate-towards a new standard. Prostate Cancer Prostatic Dis. 2007. 10:Suppl 1. S10–S14.

51. Ruszat R, Lehmann K, Wyler S, Forster T, Schurch L, Straumann U, et al. 24 months results of a prospective Bi-Center study of photoselective vaporization of the prostate (PVP) versus transurethral resection of the prostate (TURP) [abstract]. Eur Urol Suppl. 2007. 6:192.

52. de la Rosette J, Alivizatos G. Lasers for the treatment of bladder outlet obstruction: are they challenging conventional treatment modalities? Eur Urol. 2006. 50:418–420.

53. Taub DA, Wei JT. The economics of benign prostatic hyperplasia and lower urinary tract symptoms in the United States. Curr Urol Rep. 2006. 7:272–281.

54. Chirikos TN, Sanford E. Cost consequences of surveillance, medical management or surgery for benign prostatic hyperplasia. J Urol. 1996. 155:1311–1316.

55. de la Rosette J, Kortmann BB, Rossi C, Sonke GS, Floratos DL, Kiemeney LA. Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms. J Urol. 2002. 167:1734–1739.

56. DiSantostefano RL, Biddle AK, Lavelle JJ. The long-term cost effectiveness of treatments for benign prostatic hyperplasia. Pharmacoeconomics. 2006. 24:171–191.

57. Vela-Navarrete R, Gonzalez-Enguita C, Garcia-Cardoso JV, Manzarbeitia F, Sarasa-Corral JL, Granizo JJ. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002). BJU Int. 2005. 96:1045–1048.

58. Stovsky MD, Griffiths RI, Duff SB. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia. J Urol. 2006. 176:1500–1506.

59. Alivizatos G, Skolarikos A. Photoselective vaporization of the prostate. Review of cost implementation to BPH treatment. Prostate Cancer Prostatic Dis. 2007. 10:S15–S20.

60. Te AE. Current state of the art photoselective vaporization prostatectomy: laser therapy for benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2007. 10:S2–S5.